Ispecimen Inc. current report, 13 August 2021

Business Context and Reporting Period

This Form 8-K Current Report was filed by iSpecimen Inc. (ISPC) on August 16, 2021, covering events occurring on August 13, 2021. The filing details the entry into a new material definitive agreement to secure debt financing and the simultaneous termination of prior debt obligations.

Key Financial Metrics and Debt Structure

  • New Debt Facility: Entered into a Loan and Security Agreement with Bridge Bank (a division of Western Alliance Bank) for a maximum principal amount of $5,000,000.
  • Drawdown Status: $3,500,000 was advanced immediately on the closing date; $1,500,000 remains available as a revolving term loan for 18 months subject to conditions.
  • Interest Rate: Prime rate plus 0.75% per annum.
  • Repayment Terms: Interest-only payments required through February 2023. Principal and interest amortization over 30 months begins March 10, 2023. Full maturity date is August 10, 2025.
  • Collateral: Secured by substantially all company assets, excluding intellectual property.
  • Equity Component: Issued a warrant to purchase 12,500 shares of common stock at an exercise price of $8.00 per share (expires in 10 years).
  • Use of Proceeds: Proceeds were used to repay in full all outstanding secured promissory notes issued between 2018 and 2020, including related party notes.

Material Changes Versus Prior Period

The primary material change is the refinancing of the company's debt structure. The company terminated its previous "Bridge Notes" (secured promissory notes) and replaced them with a single, larger term loan facility. This action consolidates prior indebtedness into a new agreement with a defined maturity date of 2025 and specific financial covenants.

Guidance, Covenants, and Risks

  • Financial Covenants: The new agreement requires the company to achieve specific EBITDA levels and maintain a certain Adjusted Quick Ratio.
  • Negative Covenants: The agreement limits transfers, capital expenditures, additional indebtedness, liens, investments, acquisitions, and asset dispositions.
  • Events of Default: Includes cross-defaults and change of control provisions.
  • Unregistered Securities: The Lender Warrant was issued under Section 4(a)(2) of the Securities Act of 1933.
  • Management Commentary: The filing does not provide forward-looking revenue guidance or management commentary beyond the terms of the loan agreement.

Investor Verification Checklist

  • Verify the company's current EBITDA and Adjusted Quick Ratio to ensure compliance with the new financial covenants.
  • Confirm the total amount of debt repaid to related parties versus third parties under the terminated Bridge Notes.
  • Monitor the company's cash flow to ensure it can meet interest-only payments through February 2023 and subsequent principal amortization.
  • Review the impact of the 12,500 warrant shares on potential future dilution, noting the $8.00 exercise price.
  • Check for any subsequent filings regarding the drawdown of the remaining $1,500,000 available under the facility.